Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is a double blind randomized controlled study to evaluate the effect of aldactone on
peritoneal fibrosis on incident peritoneal dialysis patients. The study would include a total
of 40 incident peritoneal dialysis patients. Peritoneal biopsy would be made at randomization
and 6 months after the intervention to evaluate the effect of renin angiotensin blockade on
peritoneal fibrosis.